Moreover, we also preliminarily discovered that knocking down ZNF185 served as increasing the chemosensitivity via SMAD4 in pancreatic cancer which was confirmed by in vitro and in vivo analysis. This evidence concerns the gene ZNF185 and familial pancreatic carcinoma.